FISCHER

Fischer Medical Ventures Limited

Medical technology platform in imaging, diagnostics and healthcare services

Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies

fischermv.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹29.66
Market cap
2,072 Cr
Stock P/E
121.1
P/B
5.05
Dividend yield
0.0%
ROE (FY26)
8.1%
ROCE (FY26)
11.4%
Operating margin (FY26)
13.0%
Debt / equity (FY26)
0.19
OCF / EBITDA (FY26)
-235.0%
OCF / EBITDA (3Y)
-403.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Fischer Medical Ventures sells MRI and other medical imaging systems, together with preventive-health screening and wellness solutions, to hospitals and public health programmes in India and Southeast Asia.

Company snapshot

3rdBy market cap

Ranked among 8 companies in Medical Equipment & Supplies.

What we see

Positives
  • ✓Debt-to-equity of 0.19x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Over the last three years operations used more cash than they brought in, despite an operating profit — the business is not yet turning its profit into cash.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales21 Cr10 Cr40 Cr12 Cr49 Cr23 Cr86 Cr101 Cr98 Cr82 Cr
Operating expenses (approx.)18 Cr10 Cr39 Cr11 Cr47 Cr19 Cr70 Cr80 Cr97 Cr71 Cr
EBITDA3 Cr-0.18 Cr0.49 Cr0.50 Cr3 Cr4 Cr16 Cr22 Cr1 Cr11 Cr
OPM %12.1%-1.7%1.2%4.2%5.1%18.2%18.8%21.3%1.0%13.7%
Other income0.47 Cr0.74 Cr0.22 Cr0.38 Cr0.15 Cr7 Cr2 Cr1 Cr1 Cr1 Cr
Interest0.05 Cr0.13 Cr0.05 Cr0.07 Cr0.23 Cr0.67 Cr0.92 Cr0.64 Cr4 Cr4 Cr
Depreciation0.18 Cr0.28 Cr0.29 Cr0.56 Cr0.51 Cr0.77 Cr0.51 Cr0.77 Cr0.93 Cr1 Cr
Profit before tax3 Cr0.08 Cr0.21 Cr0.12 Cr2 Cr10 Cr17 Cr21 Cr-2 Cr8 Cr
Tax %6.1%253.9%-39.5%336.3%27.6%50.8%19.5%9.2%-214.5%51.6%
Net profit3 Cr-0.12 Cr0.29 Cr-0.29 Cr1 Cr5 Cr14 Cr19 Cr-7 Cr4 Cr
EPS (₹)₹0.65₹0.16₹0.05₹-0.05₹0.09₹0.77₹2.15₹0.30₹-0.11₹0.06

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales21 Cr111 Cr309 CrSign in free for the trailing twelve months
Operating expenses (approx.)19 Cr107 Cr265 CrSign in free for the trailing twelve months
EBITDA2 Cr3 Cr43 CrSign in free for the trailing twelve months
OPM %8.9%3.0%14.0%Sign in free for the trailing twelve months
Other income0.50 Cr1 Cr12 CrSign in free for the trailing twelve months
Interest0.07 Cr0.47 Cr6 CrSign in free for the trailing twelve months
Depreciation0.18 Cr2 Cr3 CrSign in free for the trailing twelve months
Profit before tax2 Cr2 Cr46 CrSign in free for the trailing twelve months
Tax %12.9%45.7%33.1%Sign in free for the trailing twelve months
Net profit2 Cr1 Cr31 CrSign in free for the trailing twelve months
EPS (₹)₹1.67₹0.22₹0.48Sign in free for the trailing twelve months
Dividend payout %0.0%0.0%0.9%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital54 Cr64 Cr65 Cr
Reserves28 Cr274 Cr319 Cr
Borrowings2 Cr60 Cr72 Cr
Other liabilities4 Cr59 Cr214 Cr
Total liabilities86 Cr457 Cr671 Cr
Fixed assets (net)9 Cr14 Cr12 Cr
CWIP—1 Cr3 Cr
Investments1 Cr11 Cr118 Cr
Inventories4 Cr9 Cr13 Cr
Trade receivables23 Cr76 Cr289 Cr
Cash & bank0.95 Cr104 Cr12 Cr
Other assets47 Cr242 Cr225 Cr
Total assets86 Cr457 Cr671 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity-7 Cr-86 Cr-101 Cr
Cash from investing-31 Cr-125 Cr-5 Cr
Cash from financing37 Cr315 Cr14 Cr
Net cash flow-2 Cr103 Cr-92 Cr
Free cash flow (OCF − Capex)-8 Cr-92 Cr-103 Cr

Ratios

MetricMar 2024Mar 2025Mar 2026
ROCE %2.6%0.7%11.4%
ROE %2.3%0.4%8.1%
Debtor days398250341
Inventory days1043074
Days payable5068600
Cash conversion cycle452212-185
OCF / EBITDA %-395.3%n.m.-235.0%
OCF / EBITDA % (3 years)——-403.8%
Debt / equity0.020.180.19
Current ratio18.424.481.62
Net debt / EBITDA0.39-13.221.40